mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.001 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.78 |
0.002 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.002 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.003 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |